TRLV stock news · Trulieve Cannabis Corp.
Get alerts for TRLV
Follow Trulieve Cannabis Corp. (TRLV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TRLVFree on the App Store and Google Play, or on the web.
Cantor Fitzgerald says Trulieve Cannabis Corp. is a good buy and sets a $15 price target.
NeutralCantor Fitzgerald kept its favorable rating and $15-per-share target for Trulieve. Since neither changed and no new company results were reported, this does not change how we read the company.
Trulieve Cannabis Corp. got federal approval for its medical marijuana dispensaries.
Good or bad for TRLV?12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralThe article reports Trulieve Cannabis shares fell 9%, but gives no company news behind the move. It does not change the business outlook.
Trulieve Cannabis Corp. finalizes asset acquisition or disposition (TRLV).
NeutralTrulieve Cannabis Corp. has completed an acquisition, as disclosed in their recent SEC filing. This strategic move is expected to strengthen their market position and operational capabilities, making it a significant development for investors.